Stockscreener 앱 받기
10.50
1.32%
-0.14
시간 외 거래:
10.47
-0.03
-0.29%
전일 마감가:
$10.64
열려 있는:
$10.6
하루 거래량:
6,367
Relative Volume:
5.00
시가총액:
$95.53M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$10.40
$10.60
1주일 범위
$10.34
$11.64
52주 변동 폭
$10.34
$11.64
Research Alliance Corp Iv Stock (RACD) Company Profile
Compare RACD vs LION, XXI, CCXI, UMAC, DMII
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RACD
Research Alliance Corp Iv
|
10.50 | 96.81M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
13.62 | 4.06B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.41 | 1.87B | 0 | 4.35M | 456.40K | 0.3397 |
CCXI
Churchill Capital Corp Xi
|
14.61 | 876.72M | 0 | 0 | 0 | 0.0647 |
UMAC
Unusual Machines Inc
|
16.64 | 885.14M | 17.25M | -5.64M | -40.16M | -0.3337 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.09 | 642.10M | 0 | 8.58M | -1.11M | 0.134 |
Research Alliance Corp Iv 주식(RACD)의 최신 뉴스
RACD SEC FilingsResearch Alliance Corp IV 10-K, 10-Q, 8-K Forms - Stock Titan
Research Alliance Corp IV (RACD) grants 275,000 shares to director entity - Stock Titan
Research Alliance Corp IV (RACD) sponsor gets 275K share grant - Stock Titan
Research Alliance Corporation IV (RACD) Stock Price, News & Analysis - MarketBeat
Research Alliance Corporation IV (RACD) seeks $75M SPAC IPO - Stock Titan
Book value per share of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
RACD Price Today: Research Alliance Corporation IV Stock Price, Quote & Chart - MEXC
Price to sales forward of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
Research Alliance Corporation IV (RACD) 10K Form and Latest SEC Filings 2026 - MarketBeat
Research Alliance Corporation IV (RACD) Stock Trends and Sentiment 2026 - MarketBeat
Research Alliance Corporation IV Prices $75 Million IPO, Targets Healthcare Sector on Nasdaq - Minichart
Research Alliance IV Completes $75 Million SPAC IPO, Inks Trust, Underwriting and $2.75 Million Private Deal - TradingView
Research Alliance Corporation IV (RACD) completes $75M IPO and trust funding - Stock Titan
[S-1/A] Research Alliance Corp IV Amends IPO Registration Statement - Stock Titan
Research Alliance Corp IV (RACD) director reports 30K Class B convertible shares - Stock Titan
Research Alliance Corp IV (RACD) CFO files initial ownership statement - Stock Titan
Research Alliance Corp IV (RACD) officer Henry Stusnick files initial Form 3 - Stock Titan
Research Alliance IV prices $75M SPAC IPO - MSN
Research Alliance Corporation IV(NasdaqCM: RACD) added to NASDAQ Composite Index - marketscreener.com
Research Alliance Corporation IV prices $75 million IPO at $10.00 per share - scanx.trade
Research Alliance Corporation IV prices $75M IPO on Nasdaq By Investing.com - Investing.com South Africa
Research Alliance Corporation IV prices $75M IPO on Nasdaq - Investing.com
Research Alliance Corporation IV (RACD) Prices $75M IPO - SPACInsider
Research Alliance IV (RACD) Stock Price, News & Analysis - Stock Titan
RACD|Research Alliance IV Ord Shs Class A|Price:10.235|Chg%:-0.405 - TradingKey
Research Alliance Corp IV (RACD) launches $75M healthcare SPAC IPO - Stock Titan
[EFFECT] Research Alliance Corp IV SEC Filing - Stock Titan
Research Alliance Corporation IV has completed an IPO in the amount of $75 million. - marketscreener.com
Form S-1/A Research Alliance Corporation IV For: 8 July By Investing.com - Investing.com Nigeria
Lilly offers up to $1B for Alzheimer’s drug; Bial cuts failed Parkinson’s drug - Endpoints News
RA Capital banks $75M for a biotech SPAC - Yahoo Finance
New HighStock ScreenerSnapshot - Finviz
RA Capital targets China with latest SPAC deal - Yahoo Finance
CHAR Stock Price and Chart — NASDAQ:CHAR - TradingView
Research Alliance Corp Iv (RACD) 재무 분석
Research Alliance Corp Iv (RACD)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.92%
0.20%
자본화:
|
볼륨(24시간):